Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

EVO

Evotec (EVO)

Evotec SE
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EVO
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202414h30GlobeNewswire Inc.CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher DiseaseNASDAQ:EVOEvotec SE
24/04/202413h29IH Market NewsTesla Surges 12% with 2025 Affordable Vehicle Promise, Evotec Slumps 36% on Uncertain Outlook, and Latest EarningsNASDAQ:EVOEvotec SE
18/04/202413h27PR Newswire (US)EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTSNASDAQ:EVOEvotec SE
03/01/202422h59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVOEvotec SE
08/11/202312h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVOEvotec SE
07/11/202307h30GlobeNewswire Inc.Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology PipelineNASDAQ:EVOEvotec SE
29/08/202315h59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVOEvotec SE
28/07/202313h41IH Market NewsFriday’s Wall Street Highlights: AMD, Intel, First Solar, Sleep Number, Roku, P&G, and moreNASDAQ:EVOEvotec SE
27/07/202322h32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVOEvotec SE
21/06/202322h14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
20/06/202319h24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
30/05/202323h25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EVOEvotec SE
16/05/202315h00GlobeNewswire Inc.Galaxy Gaming® and Evolution Extend Licensing Agreement for 10 YearsNASDAQ:EVOEvotec SE
15/05/202312h30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
12/05/202323h32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:EVOEvotec SE
12/05/202322h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
09/05/202322h38Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
07/04/202316h54Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
28/03/202316h28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
28/03/202316h13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
02/02/202319h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EVOEvotec SE
16/11/202212h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
09/11/202212h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
17/10/202213h00Business WireTIAP and Evotec Expand LAB150 BRIDGE Partnership to Include AmgenNASDAQ:EVOEvotec SE
11/08/202212h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
10/08/202207h30Business WireJust – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303NASDAQ:EVOEvotec SE
23/06/202217h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
09/06/202212h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
07/06/202217h37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
12/04/202214h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EVOEvotec SE
 Showing the most relevant articles for your search:NASDAQ:EVO